Exchange: NYSE·Updated 07:30 PM EDT

PEN News

News
all
press releases
New STORM-PE Data Demonstrate Correlation Between Clinical Assessments and Real-world Functional Recovery Captured Through Wearable Technology in Patients with Pulmonary Embolism
New STORM-PE Data Demonstrate Correlation Between Clinical Assessments and Real-world Functional Recovery Captured Through Wearable Technology in Patients with Pulmonary Embolism New STORM-PE Data Demonstrate Correlation Between Clinical Assessments and Real-world Functional Recovery Captured...
PR Newswire
New STORM-PE Data Demonstrate Correlation Between Clinical Assessments and Real-world Functional Recovery Captured Through Wearable Technology in Patients with Pulmonary Embolism
New STORM-PE Data Demonstrate Correlation Between Clinical Assessments and Real-world Functional Recovery Captured Through Wearable Technology in Patients with Pulmonary Embolism New STORM-PE Data Demonstrate Correlation Between Clinical Assessments and Real-world Functional Recovery Captured...
PR Newswire
More News
IART vs. PEN: Which Stock Is the Better Value Option?
IART vs. PEN: Which Stock Is the Better Value Option?
Zacks
IART or PEN: Which Is the Better Value Stock Right Now?
IART vs. PEN: Which Stock Is the Better Value Option?
Zacks
Reasons to Retain Penumbra Stock in Your Portfolio for Now
PEN's portfolio expansion and international growth support momentum, while rising costs, FX exposure and margin pressure remain key risks.
Zacks
TFX vs. PEN: Which Stock Is the Better Value Option?
TFX vs. PEN: Which Stock Is the Better Value Option?
Zacks
TFX or PEN: Which Is the Better Value Stock Right Now?
TFX vs. PEN: Which Stock Is the Better Value Option?
Zacks
TFX vs. PEN: Which Stock Is the Better Value Option?
TFX vs. PEN: Which Stock Is the Better Value Option?
Zacks
Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?
AngioDynamics' Med Tech growth and reimbursement gains strengthen its outlook, but tariffs, rising costs and execution risks keep the buy case uncertain.
Zacks
Penumbra, Inc. Reports Second Quarter 2026 Financial Results
Penumbra, Inc. Reports Second Quarter 2026 Financial Results Penumbra, Inc. Reports Second Quarter 2026 Financial Results PR Newswire ALAMEDA, Calif., July 30, 2026 ALAMEDA, Calif., July 30, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leadingthrombectomy company, today reported...
PR Newswire
THUNDER Study Demonstrates Penumbra's THUNDERBOLT is Safe and Effective for Stroke Care
THUNDER Study Demonstrates Penumbra's THUNDERBOLT is Safe and Effective for Stroke Care THUNDER Study Demonstrates Penumbra's THUNDERBOLT is Safe and Effective for Stroke Care PR Newswire ALAMEDA, Calif., July 22, 2026 First and only CAVT device for stroke demonstrated high revascularization rates...
PR Newswire

Advertisement|Remove ads.